Summary

Overview
Global Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.
Vaccination is one of the most significant public health interventions of the modern era. It has played a pivotal role in eradicating, controlling or reducing the prevalence of numerous deadly diseases, from smallpox to polio. However, the efficacy of vaccines not only depends on the science behind them but also on their safe and secure packaging.
The vaccine packaging market is a dynamic sector that intersects the worlds of healthcare, pharmaceuticals and packaging materials. Its importance has been magnified in recent years, given the spotlight on vaccines during the COVID-19 pandemic as vaccines need to be stored within a specific temperature range to maintain their potency.
The primary packaging, accounts for over 1/3rd of the market share. Similarly, the Asia-Pacific dominates the vaccine packaging market, capturing the largest market share of over 1/3rd. Growing vaccination access to emerging economies and presence of key players are major reason behind the region’s dominance.
Dynamics
Advanced Cold Chain Logistics coupled with Sustainability and Environmental Concerns
Maintaining the cold chain is crucial for vaccine effectiveness. Vaccines must be stored and transported at specific temperatures to prevent spoilage. The respective fact has led to advancements in cold chain logistics and packaging. In response to this need, companies like Sonoco ThermoSafe launched innovative packaging solutions such as Pegasus ULD, designed for air cargo shipments of vaccines at precise temperatures.
Moroever, there is a growing emphasis on sustainability and environmentally friendly packaging solutions. Governments and organizations are seeking packaging materials that are not only functional but also environmentally responsible. In 2021, the European Medicines Agency (EMA) emphasized the importance of eco-friendly vaccine packaging. Companies have responded with recyclable and biodegradable packaging options.
Increasing Access to Vaccines in Emerging Markets
The need for vaccines is not limited to developed countries. Emerging markets, with growing populations and healthcare needs, have become significant drivers in the vaccine packaging industry. Governments and organizations are working to improve access to vaccines in these regions, necessitating robust packaging solutions.
For example, the Bill and Melinda Gates Foundation has been actively involved in funding and supporting vaccine delivery initiatives in developing countries. Such initiatives play crucial role in not only making vaccines available to emerging economies, but also boosts the need for vaccine packaging to transport vaccines in to these emerging economies.
Growing Global Vaccination Efforts
The most significant driver in the vaccine packaging market is the global push for vaccination. With vaccination campaigns against COVID-19 and other diseases, there is a growing need for efficient, safe and secure vaccine packaging to ensure the efficacy of these life-saving products. Governments globally are investing heavily in vaccination programs.
For instance, in U.S., the Centers for Disease Control and Prevention (CDC) reported that more than 601 million COVID-19 vaccine doses had been administered by May 2021. The respective statistics is an indicator of growing vaccination throughout the world. Thus, global vaccination efforts acts major driver for the market.
Growing Need for Regulatory Compliance
Vaccine packaging is subject to stringent regulations imposed by health authorities globally. Such regulations are in place to ensure the safety and efficacy of vaccines. However, compliance can be a significant restraint for companies operating in this market. Meeting regulatory requirements demands substantial investments in research, development and quality control.
In response to the aforementioned challenges, packaging companies have developed solutions that meet regulatory standards. For instance, Schott AG introduced the iQ platform in 2020, which provides a comprehensive approach to quality control, helping vaccine manufacturers maintain compliance throughout the packaging process.
A series of Cold Chain Challenges
One of the most significant restraints in the vaccine packaging market is the need to maintain a cold chain throughout the distribution process. Many vaccines, especially those for diseases like measles, mumps, rubella and COVID-19, require strict temperature control to remain effective. According to the World Health Organization (WHO), up to 50% of vaccines may be wasted globally each year due to temperature control issues during transportation and storage.
In response to these challenges, several innovations have emerged. In 2020, for example, Sonoco ThermoSafe introduced the Pegasus ULD, a temperature-controlled container designed for air transport. The product aims to address cold chain issues by providing a reliable solution for the safe transport of vaccines and other temperature-sensitive pharmaceuticals.
Segment Analysis
The global vaccine packaging market is segmented based on type, level, end-user and region.
Growing need to ensure safe and effective distribution of vaccines
The global vaccine packaging market plays a crucial role in ensuring the safe and effective distribution of vaccines globally. Within this market, the segment dedicated to vaccine cool bags is of paramount importance. Such products are designed to maintain the required temperature for vaccines during transportation and storage, addressing one of the most critical challenges in vaccine distribution.
The World Health Organization (WHO) estimates that over 50% of vaccines are wasted each year due to temperature deviations. The startling figure emphasizes the need for robust temperature control measures during vaccine distribution. In U.S., the Centers for Disease Control and Prevention (CDC) has reported that vaccine wastage due to temperature issues can range from 25% to 50%.
The statistics from government sources highlight the challenges faced in vaccine distribution due to temperature deviations, emphasizing the need for effective temperature control solutions. As the world continues to grapple with the importance of vaccination in public health, vaccine cool bags play a pivotal role in ensuring that vaccines reach their intended recipients in safe and effective conditions.
Geographical Penetration
Increasing Vaccine Production, Rising Healthcare Awareness and A Growing Focus On Quality and Safety In the Pharmaceutical Sector
Asia-Pacific has emerged as a key player in the global vaccine packaging market, driven by a combination of factors including increasing vaccine production, rising healthcare awareness and a growing focus on quality and safety in the pharmaceutical sector. The importance of vaccine packaging cannot be overstated. It plays a crucial role in preserving the potency and efficacy of vaccines, ensuring that they reach patients in optimal condition.
Asia-Pacific has rapidly evolved into a hub for vaccine production. With countries such as India and China at the forefront, the region manufactures a significant portion of the world's vaccines. The respective development has naturally spurred growth in the vaccine packaging sector. Moreover, government investments and initiatives aimed at bolstering the pharmaceutical sector have further fueled the vaccine packaging market's growth.
While the Asia-Pacific has made significant strides in vaccine packaging, it's not without its challenges. Ensuring the quality and safety of vaccine packaging materials, as well as meeting the increasing demand for vaccines, are ongoing concerns. However, with government support, private sector innovation and a growing awareness of the importance of vaccine packaging, the Asia-Pacific is poised for continued growth in this vital sector.
Competitive Landscape
The major global players in the market are Gerresheimer AG, West Pharmaceutical Services, Inc, Becton, Dickinson & Company, SCHOTT AG, SGD S.A., Catalent, Inc, Stevanato Group, Nipro Corporation, Piramal Glass Private Limited and UDG Healthcare plc.
COVID-19 Impact Analysis
The COVID-19 pandemic, which began in late 2019, has had profound effects on every aspect of our lives, including the healthcare and pharmaceutical industries. One of the critical components of the global response to the pandemic has been the development and distribution of vaccines. The vaccine packaging industry plays a pivotal role in ensuring the safe and efficient delivery of vaccines globally.
The COVID-19 pandemic triggered an unprecedented global demand for vaccines. Pharmaceutical companies raced to develop vaccines to combat the virus, leading to a significant increase in vaccine production. The respective surge in vaccine production, in turn, had a direct impact on the vaccine packaging market.
According to U.S. Food and Drug Administration (FDA), as of December 2020, over 250 COVID-19 vaccine candidates were in various stages of development. The aforementioned statistics is translated to an enormous demand for vaccine packaging materials such as vials, ampoules, syringes and vial seals. Companies were forced to develop packaging solutions that could ensure the safe storage and transportation of vaccines at various temperature requirements.
Russia-Ukraine War Impact Analysis
Armed conflicts in key manufacturing regions, such as Ukraine, can disrupt global supply chains. Ukraine, for example, is known for its production of pharmaceutical and chemical products, including packaging materials. Any interruptions in the supply of materials from conflict zones can lead to shortages and increased prices for packaging materials, affecting vaccine production and distribution.
Further, global supply chain disruptions often lead to increased transportation and logistics costs. Manufacturers may need to find alternative suppliers or transportation routes, which can result in higher expenses. Such increased costs may be passed on to consumers, healthcare providers and governments purchasing vaccines.
Moroever, the eopolitical instability can also lead to regulatory challenges. Regulatory agencies in various countries may impose stricter controls or inspections on products originating from or passing through conflict zones. Such additional requirements can create delays in getting vaccines to market.
By Type
• Vaccine Cool Bags
• Vials and Ampoules
• Corrugated Boxes
• Others
By Level
• Primary
• Secondary
• Tertiary
By End-User
• Biopharmaceutical Companies
• Hospitals
• Medical Laboratories
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Russia
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In 2023, Va-Q-tec, a portable and reusable temperature-controlled packaging solution lunched COOLPACK, a vaccine cool bag designed for the safe transportation of vaccines, particularly in regions with limited infrastructure. The COOLPACK's innovative design allows it to maintain temperature for extended periods, addressing the challenges of vaccine distribution in remote areas.
• In 2021, Sonoco ThermoSafe introduced the Pegasus ULD, a unit load device designed for the air transportation of temperature-sensitive pharmaceuticals, including vaccines. The product features advanced insulation and phase change materials, ensuring precise temperature control and protection during air travel, which is crucial for the global distribution of vaccines.
• Softbox introduced the Tempcell ECO in 2022. The product is a single-use, fully-recyclable packaging solution, designed for the transportation of temperature-sensitive pharmaceuticals and vaccines. It offers temperature control for up to 168 hours, making it ideal for long-distance vaccine distribution.
Why Purchase the Report?
• To visualize the global vaccine packaging market segmentation based on type, level, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of vaccine packaging market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global vaccine packaging market report would provide approximately 61 tables, 59 figures and 192 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents